Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Aurich

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pharmaceutics|June 2, 2021
Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping ReviewBeate Aurich, Evelyne Jacqz-Aigrain
Pharmacoepidemiology and Drug Safety|February 26, 2011
Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adultsBeate Aurich-Barrera, Lynda Wilton, David Brown, et al.
Drug Safety|August 13, 2010
Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in EnglandBeate Aurich-Barrera, Lynda Wilton, David Brown, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 11, 2019
Reporting of offspring data in diabetes, HIV infection and hypertension trials during pregnancy: a systematic reviewBeate Aurich, Tania Martin-Montoya, Daolun Zhang, et al.
Drug Safety|January 10, 2009
Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring studyBeate Aurich-Barrera, Lynda V Wilton, Saad A W Shakir
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 1, 2005
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in EnglandBeate Aurich Barrera, Lynda Wilton, Scott Harris, et al.
Drug Safety|February 4, 2006
Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in EnglandBeate Aurich-Barrera, Lynda Wilton, Scott Harris, et al.
American Journal of Perinatology|April 26, 2018
Capacities and Competences for Drug Evaluation in European Neonatal Intensive Care Units: A Survey and Key Issues for ImprovementValery Elie, Virginia Neyro, Phuong Ha, et al.
Clinical Drug Investigation|December 14, 2017
Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in ChildrenPauline Lancia, Beate Aurich, Phuong Ha, et al.
Drug Safety|January 27, 2007
Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patientsRachna Kasliwal, Lynda V Wilton, Victoria Cornelius, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pharmaceutics|June 2, 2021
Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping ReviewBeate Aurich, Evelyne Jacqz-Aigrain
Pharmacoepidemiology and Drug Safety|February 26, 2011
Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adultsBeate Aurich-Barrera, Lynda Wilton, David Brown, et al.
Drug Safety|August 13, 2010
Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in EnglandBeate Aurich-Barrera, Lynda Wilton, David Brown, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 11, 2019
Reporting of offspring data in diabetes, HIV infection and hypertension trials during pregnancy: a systematic reviewBeate Aurich, Tania Martin-Montoya, Daolun Zhang, et al.
Drug Safety|January 10, 2009
Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring studyBeate Aurich-Barrera, Lynda V Wilton, Saad A W Shakir
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 1, 2005
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in EnglandBeate Aurich Barrera, Lynda Wilton, Scott Harris, et al.
Drug Safety|February 4, 2006
Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in EnglandBeate Aurich-Barrera, Lynda Wilton, Scott Harris, et al.
American Journal of Perinatology|April 26, 2018
Capacities and Competences for Drug Evaluation in European Neonatal Intensive Care Units: A Survey and Key Issues for ImprovementValery Elie, Virginia Neyro, Phuong Ha, et al.
Clinical Drug Investigation|December 14, 2017
Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in ChildrenPauline Lancia, Beate Aurich, Phuong Ha, et al.
Drug Safety|January 27, 2007
Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patientsRachna Kasliwal, Lynda V Wilton, Victoria Cornelius, et al.
Pageof 2